MEDANTA - Technical Analysis with Chart Patterns & Indicators
Back to ListTechnical Rating: 4.3
| Stock Code | MEDANTA | Market Cap | 32,601 Cr. | Current Price | 1,212 ₹ | High / Low | 1,456 ₹ |
| Stock P/E | 65.7 | Book Value | 149 ₹ | Dividend Yield | 0.04 % | ROCE | 17.1 % |
| ROE | 13.2 % | Face Value | 2.00 ₹ | DMA 50 | 1,157 ₹ | DMA 200 | 1,171 ₹ |
| Chg in FII Hold | -0.39 % | Chg in DII Hold | 0.77 % | PAT Qtr | 124 Cr. | PAT Prev Qtr | 107 Cr. |
| RSI | 55.1 | MACD | 32.0 | Volume | 1,55,577 | Avg Vol 1Wk | 1,43,926 |
| Low price | 955 ₹ | High price | 1,456 ₹ | PEG Ratio | 2.80 | Debt to equity | 0.06 |
| 52w Index | 51.2 % | Qtr Profit Var | -3.54 % | EPS | 18.5 ₹ | Industry PE | 47.0 |
📊 MEDANTA is trading at 1,212 ₹, above both its 50 DMA (1,157 ₹) and 200 DMA (1,171 ₹), confirming short-term strength. RSI at 55.1 indicates moderate momentum, not overbought. MACD at 32.0 is strongly positive, reinforcing bullish bias. Bollinger Bands show price moving toward the upper band, suggesting upside momentum. Current volume (1,55,577) is slightly above the 1-week average (1,43,926), supporting accumulation interest.
- 💰 Optimal Buy Price: 1,190 – 1,210 ₹ (support near DMA levels)
- 📈 Profit-Taking Exit Levels: 1,250 ₹ (first resistance), 1,300 ₹ (trendline resistance)
- 📉 Stop-Loss / Loss Protection: 1,170 ₹ (below support)
- ⏱️ Trend Status: Trending upward with bullish bias; breakout above 1,250 ₹ could confirm continuation.
Positive
✅ PAT growth (124 Cr. vs 107 Cr.) shows earnings momentum.
✅ ROCE at 17.1% and ROE at 13.2% reflect healthy returns.
✅ Trading above both 50 DMA and 200 DMA confirms bullish trend.
✅ EPS at 18.5 ₹ supports valuation strength.
✅ DII holdings increased (+0.77%), showing domestic investor confidence.
Limitation
⚠️ Stock P/E of 65.7 is high compared to industry average (47.0).
⚠️ PEG ratio of 2.80 suggests stretched valuation.
⚠️ FII holdings decreased (-0.39%), showing reduced foreign investor interest.
⚠️ Dividend yield at 0.04% is very low, limiting income appeal.
⚠️ Quarterly profit variation (-3.54%) shows inconsistency in earnings.
Company Negative News
🚫 Valuation concerns due to high P/E and PEG ratio.
🚫 Reduced FII participation may weigh on sentiment.
🚫 Slight decline in quarterly profit adds caution.
Company Positive News
🌟 Strong earnings growth compared to previous quarter.
🌟 Increased DII support reflects domestic confidence.
🌟 Technical indicators show bullish momentum with price above key averages.
Industry
🏭 Industry P/E at 47.0 is lower than MEDANTA’s 65.7, showing overvaluation relative to peers.
🏭 Healthcare sector demand remains strong, supporting long-term growth outlook.
Conclusion
📌 MEDANTA is trending upward with bullish technical signals. Entry near 1,190 – 1,210 ₹ offers favorable positioning, while exits at 1,250 – 1,300 ₹ should be monitored. Stop-loss protection at 1,170 ₹ is advised. Strong fundamentals support the uptrend, though valuations remain stretched and quarterly profit variation adds caution.
Would you like me to expand this into a swing trade analysis for 1–2 week holding periods, or keep the focus strictly on this intraday technical view?